Skip to main content
. 2018 Feb 6;8:2459. doi: 10.1038/s41598-018-20911-2

Figure 1.

Figure 1

The effect of thalidomide on infarct volume of the MCAO/R model. (a) Experimental design. Animals underwent 1.5 h of middle cerebral artery occlusion and 24 h reperfusion time (MCAO/R). Thalidomide (20 mg/kg) or DMSO (0.66 ml/kg, vehicle) administration is shown in asterisks. Sample preparation for histological, neurological, and biochemical studies were performed at the end of reperfusion. (b) Representative photographs of TTC-stained brain slices showing the infarct area 24 h after MCAO/R. (c) Quantitative analysis of the infarct area in each slice and the total infarct volume from MCAO/R rats treated with thalidomide or vehicle. The infarct areas caused by MCAO/R were significantly decreased by the administration of thalidomide. Quantification of the infarct volume is represented by mean ± SD (n = 6 for vehicle, n = 5 for thalidomide).